View Clinical Trial (Medical Research Study)
Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction - NCT01041586-(Clinical Trial 463936)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Seattle |
|
State:
|
|
WA |
| Zip Code: |
|
|
| Conditions: |
|
Emphysema - Chronic Obstructive Pulmonary Disease |
| Purpose: |
|
To assess the safety and efficacy of BTVA for the treatment of patients with heterogeneous
upper lobe emphysema.
|
| Study summary: |
|
All subjects meeting the eligibility criteria and who provide written informed consent will
be enrolled. Immediately prior to BTVA treatment, an initial bronchoscopy will be
performed to evaluate the baseline condition of the airways and to confirm anatomy of the
lung segments targeted for BTVA treatment. Up to 3 segments in either the right or left
upper lobe will be treated with a vapor dose of 10 calories per gram of lung tissue (10
cal/g). Targeted lobe for treatment will be based on lobar disease severity. |
| Criteria: |
|
Inclusion Criteria:
1. Age: > 40 and ≤ 75 years old
2. Diagnosis of heterogeneous emphysema with upper lobe predominance
3. FEV1 < 45% predicted
4. TLC > 100% predicted
5. RV > 150% predicted
6. 6-minute walk test > 140 meters
7. mMRC ≥ 2 (mMRC)
8. Non-smoking for 3 months
9. Optimized medical management and completed pulmonary rehabilitation
Exclusion Criteria:
1. Known α-1-antitrypsin deficiency
2. BMI < 15 kg/m2 or > 35 kg / m2
3. History of pneumothorax within previous 18 months
4. History of heart and / or lung transplant, lung volume reduction surgery (LVRS),
median sternotomy, bullectomy, and/or lobectomy
5. Respiratory infections or recurring COPD exacerbations > 3 hospitalizations in past
12 months or active infection
6. History of the (EF) ≤ 40%; Stroke; Unstable Myocardial Ischemia; FEV1 < 15%
predicted; DLCO < 20% predicted; of pulmonary hypertension; indwelling pacemaker or
implantable cardiac defibrillator (ICD); pregnancy or breastfeeding |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
August 3, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|